HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest Ethiopia

Virology Journal

Yeshambel Belyhun¹  Fanaye Asfaw²  Meseret Alem²  Yitayih Wondimeneh² 

[1] Institute of Virology, Faculty of Medicine, University of Leipzig, Johannisallee 30, Leipzig, 04103, Germany;School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia

关键词: Liver enzymes;    CD4 T cells;    HIV;    HCV;    HBV;   

Others  :  1150073
DOI  :  10.1186/1743-422X-10-171

 received in 2012-09-23, accepted in 2013-05-29,  发布年份 2013

【 摘 要 】

Background

The co-existence of viral hepatitis caused by HBV and HCV become common causes of severe liver complication and immunological impairment among HIV infected individuals. The aim of this study was to assess the seroprevalence of HBV and HCV and their correlation with CD4 and liver enzyme levels among HAART naïve HIV positive individuals.

Method

A Cross-sectional study was conducted from March-May, 2011 at University of Gondar Teaching Hospital, Northwest Ethiopia. HBV and HCV serological tests and liver enzymes as well as CD4 T cell level determination were assessed following the standard procedures. Socio-demographic data was collected by using structured questionnaire. The data was entered and analyzed by using SPSS version 20.0 statistical software and p < 0.05 was considered as statistically significant.

Result

Among 400 study participants, the overall prevalence of HIV-viral hepatitis co-infection was 42(11.7%). The prevalence of HIV-HBV, HIV-HCV and HIV-HBV-HCV co-infections were 20(5.6%), 18(5.0%) and 4(1.1%) respectively. Study participants who had HIV-HBV, HIV-HCV and HIV-HBV-HCV co-infection have relatively raised mean liver enzyme levels (ALT, AST and ALP) than HIV mono-infected once. Individuals with HIV-HBV, HIV-HCV and HIV-HBV-HCV co-infection also had a lower mean CD4 levels than HIV mono-infected study participants. The mean CD4 value in males was lower than females.

Conclusion

The prevalence of HBV and HCV was higher than reports from general population of the country. Raised levels of liver enzymes and lowered mean CD4 counts were seen in HIV-HBV, HIV-HCV and HIV-HBV-HCV co-infections. These findings underscore the importance of screening all HIV positive individuals before initiating antiretroviral treatment.

【 授权许可】

   
2013 Wondimeneh et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Chen LS, Morgan RT: The natural history of Hepatitis C Virus (HCV) infection. Int J Med Sci 2006, 3(2):48-59.
• [2]Fenton K: The changing global epidemiology of HBV and HCV. Frontiers in Drug Development for Viral Hepatitis 2007, 3:3-4.
• [3]Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palù G: Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2005, 42(5):615-624.
• [4]Volf V, Marx D, Pliscova L, Sumega L, Celko A: A survey of hepatitis B and C prevalence among the homeless community of parague. Eur J Public Health 2008, 18:44-47.
• [5]Soriano V, Barreiro P, Nunez M: Management of chronic hepatitis B and C in HIV-coinfected patients. J Antimicrob Chemother 2006, 57:815-818.
• [6]Sharifi-Mood B, Metanat M: HIV/AIDs and hepatitis C Co-infection. Int J Virol 2006, 2(1):63-66.
• [7]Koziel M, Peters M: Viral hepatitis in HIV infection. New England Medical Journal 2007, 356(14):1445-1454.
• [8]Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C: Hepatitis B and HIV Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005, 19:593-601.
• [9]Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ: HIV and hepatitis C co infection within the CAESAR study. HIV Med 2004, 5:174-179.
• [10]Barth E, Quirine H, Jantjie T, Hoepelman I: Hepatitis B/C and HIV in sub-Saharan Africa. Int J Infect Dis 2010, 14(12):1024-1031.
• [11]Sulkowski M: Viral hepatitis and HIV co-infection. Journal of Hepathology 2008, 48(2):353-367.
• [12]Petrovic L: HIV/HCV co-infection, histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment. Liver Int 2007, 27:598-606.
• [13]Lincoln D, Petoumenos K, Dore G: HIV/HBV and HIV/HCV co-infection and outcomes following highly active antiretroviral therapy. HIV Med 2003, 4:241-249.
• [14]Sullivan PS, Hanson D, Teshale E, Wotring L, Brooks J: Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. AIDS 2006, 20:1171-1179.
• [15]Sulkowski M, Moore R, Mehta S, Chaisson R, Thomas D: Hepatitis C and progression of HIV disease. J Am Med Assoc 2002, 288:199-206.
• [16]Mallet V, Vallet-Pichard A, Pol S: The impact of human immunodeficiency virus on viral hepatitis. Liver Int 2011, 31(1):135-139.
• [17]Thio CL: Hepatitis B and human immunodeficiency virus coinfection. Hepathology 2009, 49(5):138-145.
• [18]Romeo R, Rumi M, Donato M, Cargne P, Vigano M, Mondelli B: Hepatitis C is more severe in drug users with human immunodeficiency virus infection. Journal of Viral Hepathology 2000, 7:297-301.
• [19]Christian B, Okuma J, Claudia H, Chalamilla G, Spiegelman D, Nagu T: Prevalence of hepatitis B and C Co-infection and response to antiretroviral therapy among HIV-infected patients in an urban setting in Tanzania. California: 17th Conference on Retroviruses & Opportunistic Infections in San Francisco; 2010.
• [20]Leeratanapetch N, Suseangrut W: Hepatitis B virus and hepatitis C virus Co-infection with HIV patients at khon kaen hospital. Khon Kaen Hospital Medical Journal 2008, 32:229-238.
• [21]Modi A, Feld J: Viral hepatitis and HIV in Africa. AIDS Review 2007, 9:25-39.
• [22]Chung R: Hepatitis C and B viruses: the new opportunists in HIV infection. Tropical HIV Medicine 2006, 14(2):78-83.
• [23]Moges F, Kebede Y, Kassu A, Mulu A, Tiruneh M, Degu G: Seroprevalence of HIV, hepatitis B infections and syphilis among street dwellers in Gondar city, Northwest Ethiopia. Ethiop J Heal Dev 2006, 20(3):5.
• [24]Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F: Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University teaching hospital Northwest Ethiopia. BMC Infect Dis 2010, 10(111):4-5.
• [25]Diro E, Alemu S, Alemu S, G/Yohannes A: Blood safety & prevalence of transfusion transmissible viral infections among donors at the Red cross blood bank in Gondar University hospital. Ethiop Med J 2008, 46(1):7-13.
• [26]Ethiopian Federal Ministry of Health: Guidelines for management of opportunistic infections and anti-retroviral treatment in adolescents and adults in Ethiopia. Addis Ababa Ethiopia: Federal HIV/AIDS Prevention and Control Office Federal Ministry of Health; 2008.
• [27]Lesi O, Kehinde M, Oguh D, Amira C: Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS. Niger Postgrad Med J 2007, 14:129-133.
• [28]Nyirenda M, Beadsworth M, Stephany P, Hart C, Hart I, Munthali C: Prevalence of infection with hepatitis B and C virus and co-infection with HIV in medical inpatients in Malawi. J Infect Dis 2008, 57:72-77.
• [29]Hussain T, Kulshreshtha KK, Sinha S, Yadav VS, Katoch VM: HIV, HBV, HCV, and syphilis co-infections among patients attending the STD clinics of district hospitals in Northern India. Int J Infect Dis 2006, 10(5):358-363.
• [30]Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P: Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Ann Hepatol 2008, 7(2):152-156.
• [31]Omosigho OP, Inyinbor HE, Emumwen GE, Mohammed SK, Ledogo G, Njab J, Oladejo OP, Omueti EA: Hepatitis C virus Co-infection in human immuno deficiency virus positive population in bida, north central Nigeria. The Internet Journal of Infectious Diseases 2011, 9:2.
• [32]Alter M: Epidemiology of viral hepatitis and HIV co-infection. Journal of Hepathology 2006, 44:6-9.
• [33]Sherman K, Rouster S, Chung R, Rajicic N: Hepatitis C virus prevalence among patients infected with human immunodeficiency virus. Clin Infect Dis 2002, 34:831-837.
• [34]Rockstroh J, Mocroft A, Soriano V, Tural C, Losso MH, Horban A: Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly antiretroviral therapy. J Infect Dis 2005, 192:992-1002.
• [35]Lodenyo H, Schoub B, Ally R, Kairu S, Segal I: Hepatitis B and C virus infections and liver function in AIDS patients at Chrishanibaragwanath hospital Johannesburg. East African Medical January 2000, 77(1):13-15.
• [36]Simpore J, Savadogo A, Ilboudo D, Nadambega C, Esposito M, Yara J: Toxoplasma gondii, HCV, and HBV seroprevalence and Co-infection among HIV positive and negative pregnant women in Burkina Faso. J Med Virol 2006, 78:730-733.
• [37]Diop-Ndiaye H, Toure’-Kane C, Etard JF, Loˆ G, Diaw PA, Ngom-Gueye NF: Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). J Med Virol 2008, 80:1332-1336.
• [38]Flatau E, Segol O, Shneour A, Tabenkin H, Raz R: Prevalence of markers of infection with hepatitis B and C viruses in immigrants of operation Solomon, 1991. Isr J Med Sci 1993, 29(6–7):387-389.
• [39]Frommel D, Tekle-Haimanot R, Berhe N, Aussel L, Verdier M, Preux PM, Denis F: A survey of antibodies to HCV in Ethiopia. AmJTrop Med Hyg 1993, 49(4):435-439.
• [40]Tsegaye E, Nordenfelt E, Hansson BG: Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic. Trans R Soc Trop Med Hyg 1995, 89(2):171-174.
• [41]Ayele W, Nokes J, Abebe A, Messele T, Dejene A, Enquselassie F: Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia. J Med Virol 2002, 68:12-17.
• [42]Dessie A, Abera B, Wale F: Seroprevalence of major blood-borne infections among blood donors at Felege Hiwot referral hospital, northwest Ethiopia. Ethiop J Health Dev 2007, 21(1):68-69.
• [43]Ayele Ayele W, Nokes DJ, Abebe A, Messele T, Dejene A, Enquselassie F, Rinke de Wit FT, Fontanet LA: Higher prevalence of anti HCV antibodies among HIV positive compared to HIV negative inhabitants of Addis Ababa Ethiopia. J Med Virol 2002, 68:12-17.
• [44]Abreha T, Woldeamanuel Y, Pietsch C, Maier M, Asrat D, Abebe A, Hailegiorgis B, Aseffa A, Liebert UG: Genotypes and viral load of HCV among persons attending a VCT center in Ethiopia. J Med Virol
• [45]Alemayehu A, Tassachew Y, Sisay Z, Shimelis T: Prevalence and risk factors of hepatitis C among individuals presenting to HIV testing centers, hawassa city southern Ethiopia. BMC Research Notes 2011, 4:193. BioMed Central Full Text
• [46]Olufemi A, Emmanuel A, Zaccheus A, Ibrahim W, Funmilayo E, Patience A: Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. Journal of Infectious DevCtries 2009, 3(5):369-375.
• [47]Kazem S, Asl H, Avijgan M, Mohamadnejad M: High prevalence of HBV, HCV, and HIV infections in gypsy population residing in Shahr-E-Kord. Arch Iranian Medicine 2004, 7(1):20-22.
• [48]Fuse V, Cornelio C, Meraldi N: Prevalence of HCV and HBV in HIV positive patients attending a general hospital in Buenos Aires. International Conference of AIDS: Argentina; 2004.
• [49]Ataei B, Tayeri K, Kassaian N: Hepatitis B and C among patients infected with human immunodeficiency virus in Isfahan, Iran: seroprevalence and associated factors. Hepatitis Monthly summer 2010, 10(3):188-192.
• [50]Tripathi A, Khanna M, Gupta N, Chandra M: Low prevalence of hepatitis B virus and hepatitis C virus Co-infection in patients with human immunodeficiency virus in northern India. Indian Journal of Physicians Association 2007, 55:430.
• [51]Cao YZ, Dieterich D, Thomas PA, Huang YX, Mirabile M, Ho DD: Identification and quantitation of HIV-1 in the liver of patients with AIDS. AIDS 1992, 6:65-70.
• [52]Akinsegun A, Adedoyin D, Adewumi A, Sarah A, Olajumoke Oshinaike KW: CD4 Count pattern and demographic distribution of treatment-Na¨ıve HIV patients in Lagos, Nigeria. AIDS Research and Treatment 2012, 2012:1-6.
• [53]Tugume SB, Piwowar EM, Lutalo T, Mugyenyi PN, Grant RM, Mangeni FW: Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol 1995, 2(2):233-235.